Human immunodeficiency virus/acquired immune deficiency syndrome-related drug therapy: anesthetic implications.
This article reviews advances in the diagnosis and treatment of human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS). Newer drugs used to treat HIV/AIDS, such as protease inhibitors and non-nucleoside reverse transcriptase inhibitors, are described, including their potential interactions with anesthetic drugs. Common areas of concern for CRNAs related to these drugs are reviewed, such as end-organ toxicity, liver and kidney effects, and bone marrow suppression.
Griffis
C A
CA
Department of Anesthesiology, UCLA Medical Center, USA.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000451:nursing / Q000601:surgery*; D000758:Anesthesia / Q000009:adverse effects / Q000379:methods* / Q000451:nursing*; D000777:Anesthetics / Q000627:therapeutic use*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004347:Drug Interactions; D006801:Humans; D009719:Nurse Anesthetists
D000777:Anesthetics; D019380:Anti-HIV Agents